Physician profile
Dmitriy Shpak
NPI 1922617752
$1,023.26
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.30 · 2022: $16.93 · 2023: $28.09 · 2024: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $850 · Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $850.00 |
| Food and Beverage | $133.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $954.94 | 2024 | |
| Kerr Corporation | $23.30 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $16.93 | 2022 | |
| Align Technology, INC. | $14.63 | 2023 | Itero Element 5d Plus Lite |
| Dentsply Sirona INC | $13.46 | 2023 | Consumable Dentistry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Shpak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.